Local neutrophil and eosinophil extracellular traps formation in pyodermatitis pyostomatitis vegetans
Related Experiment Video
Updated: Jul 16, 2025

Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli
Published on: November 4, 2022
1Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Abstract:
Pyodermatitis pyostomatitis vegetans is a rare inflammatory condition, affecting the skin and/or mucous membrane. Some cases include both skin and mucous involvement, whereas others develop either skin or mucous lesions only. The typically affected areas are the scalp, face, trunk and extremities, including the flexural areas and umbilicus. Clinical features show erosive granulomatous plaques, keratotic plaques with overlying crusts and pustular lesions. Among mucous lesions, oral mucosa is most frequently involved, and gingival erythema, shallow erosions, cobblestone-like papules on the buccal mucosa or upper hard palate of the oral cavity are also observed. Some of the lesions assume a 'snail track' appearance. Although there are several similarities between pyodermatitis pyostomatitis vegetans and other diseases, that is pyoderma gangrenosum, pemphigus vegetans and pemphigoid vegetans, the histopathological features of pyodermatitis pyostomatitis vegetans are unique in that epidermal hyperplasia, focal acantholysis and dense inflammatory infiltrates with intraepidermal and subepidermal eosinophilic microabscesses are observed. Direct immunofluorescence findings are principally negative. Activated neutrophils are supposed to play an important role in the pathogenesis of pyodermatitis pyostomatitis vegetans. The expression of IL-36 and neutrophil extracellular traps (NETs) was observed in the lesional skin, and additionally, eosinophil extracellular traps (EETs) was detected in pyodermatitis pyostomatitis vegetans. A possible pathogenic role of NETs and EETs in the innate immunity and autoinflammatory aspects of pyodermatitis pyostomatitis vegetans was discussed.
Insights
Pyodermatitis pyostomatitis vegetans is a rare inflammatory skin and mucous membrane condition. Unique histopathology and neutrophil extracellular traps (NETs) suggest a role in its autoinflammatory pathogenesis.
Area of Science:
- Dermatology
- Immunology
- Pathology
Background:
- Pyodermatitis pyostomatitis vegetans is a rare inflammatory condition affecting skin and/or mucous membranes.
- Lesions can be erosive, granulomatous, keratotic with crusts, or pustular, commonly involving the scalp, face, trunk, extremities, and oral mucosa.
- It shares similarities with pyoderma gangrenosum, pemphigus vegetans, and pemphigoid vegetans, necessitating differentiation through unique histopathological findings.
Purpose of the Study:
- To elucidate the unique histopathological features of pyodermatitis pyostomatitis vegetans.
- To investigate the role of neutrophils and extracellular traps in the pathogenesis of this condition.
Main Methods:
- Histopathological examination of lesional skin.
- Analysis of direct immunofluorescence findings.
- Assessment of IL-36 expression and neutrophil extracellular traps (NETs) and eosinophil extracellular traps (EETs) in affected tissues.
Main Results:
- Histopathology reveals epidermal hyperplasia, focal acantholysis, dense inflammatory infiltrates, and eosinophilic microabscesses.
- Direct immunofluorescence is typically negative.
- Expression of IL-36, NETs, and EETs was observed in lesional skin, indicating their potential involvement.
Conclusions:
- Pyodermatitis pyostomatitis vegetans possesses distinct histopathological characteristics.
- Activated neutrophils and the formation of NETs and EETs are implicated in the innate immunity and autoinflammatory processes of the condition.
More Related Videos
10:58Methods to Study Lipid Alterations in Neutrophils and the Subsequent Formation of Neutrophil Extracellular Traps
Published on: March 29, 2017
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024